ArticleJournal of nephrology2019

Fibroblast growth factor-23 correlates with advanced disease conditions and predicts high risk of major adverse cardiac and cerebral events in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis.

Li Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.